SYNLAB AG
SYAB | F
Overview
Corporate Details
- ISIN(s):
- DE000A2TSL71
- LEI:
- 984500883BA5AQ14C037
- Country:
- Germany
- Address:
- Moosacher Straße 88, 80809 München
- Website:
- https://www.synlab.com/
- Sector:
- Health Care
- Industry:
- Health Care Providers & Services
Description
SYNLAB offers a full range of medical diagnostic services for practising doctors, clinics and patients. The SYNLAB Group is the uncontested leader on the European market for human medicine laboratory services. SYNLAB particularly focuses on the implementation of innovative laboratory medicine methods and on networking specialist diagnostic competences (SYNLAB Centres of Excellence). SYNLAB maintains additional laboratories (strategic business units) in individual countries for veterinary medicine. This services portfolio is rounded off by expert medical imaging centres, day clinics and ambulatory services in certain countries. The group works closely with research institutions and universities and also maintains an educational institution of its own, the SYNLAB Academy.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-10-30 07:32 |
Major Shareholding Notification
Cinven to Acquire Elliotts Stake in SYNLAB AG, Squeeze-Out to Follow
|
English | 12.5 KB | |
| 2024-09-17 16:00 |
Regulatory News Service
Cinven to sell minority stake in SYNLAB to strategic investor Labcorp
|
English | 20.5 KB | |
| 2024-06-04 20:46 |
Regulatory News Service
Cybersecurity Incident at Synnovis in UK
|
English | 10.1 KB | |
| 2024-05-31 08:40 |
Delisting Announcement
SYNLAB AG: Cinven announces public delisting acquisition offer | Conclusion of …
|
English | 6.0 KB | |
| 2024-05-13 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2024
|
English | 547.7 KB | |
| 2024-05-08 07:00 |
Earnings Release
SYNLAB delivers strong performance in Q1 2024
|
English | 40.9 KB | |
| 2024-04-30 14:56 |
Regulatory News Service
SYNLAB Italy has restored operations after cyber-attack
|
English | 10.2 KB | |
| 2024-04-23 11:12 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.2 KB | |
| 2024-04-22 10:42 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 13.8 KB | |
| 2024-04-22 09:53 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.2 KB | |
| 2024-04-22 09:50 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.2 KB | |
| 2024-04-22 09:35 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 18.3 KB | |
| 2024-04-19 19:06 |
Inside Information Statement
SYNLAB AG: SYNLAB affected by cyber-attack in Italy
|
English | 5.4 KB | |
| 2024-04-19 16:17 |
Related Party Transactions
SYNLAB AG: Release according to Article 111c of the AktG [the German Stock Corp…
|
English | 6.2 KB | |
| 2024-04-19 10:17 |
Directors' Dealings
SYNLAB AG: Dr. Ute Hasholzner, sell
|
English | 7.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-10-02 | Ebsworth GmbH | Close relation | Sell | None | 107,484.01 EUR |
| 2023-10-02 | Ebsworth GmbH | Close relation | Sell | None | 7,140.00 EUR |
| 2022-05-10 | Henkel, Dr. Holger | Supervisory board | Other | None | N/A |
| 2022-05-04 | Riedel, Oliver | Board | Buy | None | 5,800.00 EUR |
| 2022-05-02 | Schmitt, Martin | Supervisory board | Buy | None | 1,071.00 EUR |
| 2021-12-21 | Lorenz-Meyer, Robert | Supervisory board | Sell | None | 8,960.90 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Ramsay Générale de Santé | France | GDS | |
|
Remedis Spolka Akcyjna W Upadlosci | Poland | REM | |
|
Salus | Slovenia | SALR | |
|
Sandoz Group AG | Switzerland | SDZ | |
|
Selcuk Ecza Deposu Ticaret ve Sanayi AS | Türkiye | SELEC | |
|
Siegfried Holding AG | Switzerland | SFZN | |
|
STRATEC SE | Germany | SBS | |
|
Ucare Services Belgique | Belgium | PNSB | |
|
Uniphar PLC | Ireland | UPR | |
|
Vita 34 AG | Germany | V3V |